WENDY GASTON: Open Payments
NPI 1548204654 · RATCLIFF, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$686 in 42 payments from 12 companies in 2025. Trend: 2023 $163 · 2024 $106 · 2025 $686
Food & beverage: $686
| Company | Payments | Amount |
|---|---|---|
| Paratek Pharmaceuticals, Inc. | 21 | $267 |
| Amgen Inc. | 5 | $89 |
| Lilly USA, LLC | 2 | $50 |
| ABBVIE INC. | 2 | $46 |
| Exact Sciences Corporation | 2 | $44 |
| AstraZeneca Pharmaceuticals LP | 2 | $43 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $42 |
| Novo Nordisk Inc | 2 | $34 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
| Axsome Therapeutics, Inc. | 1 | $18 |
Products named: NUZYRA, XHANCE, OTEZLA, VRAYLAR, Cologuard Collection Kit, CAPLYTA, EVENITY, ZEPBOUND.
Industry payments across AR — which companies pay providers there.
